This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Meyskens, F. L. Articles by Szabo, E. Search for Related Content PubMed PubMed Citation Articles by Meyskens, F. L., Jr. Articles by Szabo, E.

Diet and Cancer: The Disconnect Between Epidemiology and Randomized Clinical Trials

¹ Departments of Medicine and Biological Chemistry, Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange, California; and ² Division of Cancer Prevention, National Cancer Institute, NIH, Bethesda, Maryland

Requests for reprints: Frank L. Meyskens, Jr., Hematology/Oncology, University of California, Irvine, Cancer Center, Building 44, Route 81, 101 City Drive Cancer Center, Orange, CA 92668. Phone: 714-456-6310; Fax: 714-456-5039. E-mail: flmeyske{at}uci.edu

Dietary epidemiology has been highly successful in identifying the responsible agent in many diseases, including scurvy, pellagra, blindness, and spinal bifida. Case-control, cohort, and ecologic observational studies have consistently associated increased consumption of fruits and vegetables with a decreased risk for a wide variety of epithelial cancers and, in many cases, specific dietary components seem to decrease the risk for a wide array of epithelial cancers. Over time, there has been enthusiasm for one or another compounds, such as ß-carotene in the past and folate currently. Despite the success of translating similar epidemiologic observations to clinical benefit in other areas of medicine via the crucible of the randomized clinical trial, this strategy has not been nearly as successful for cancer. We propose that the inability of nutritional epidemiology to identify effective chemopreventive strategies is not just a problem of quantitation, but rather that the discipline is usually qualitatively incapable of identifying a dietary compound(s) that will be efficacious. One needs to consider the following basic questions in trying to understand why nutritional epidemiology has not been translated into progress in cancer prevention: Why do fruits and vegetable show a consistent protective effect against many epithelial cancers in epidemiologic studies? Once a specific dietary compound is identified as protective in observational studies, why do most subsequent observational studies confirm the effect? Why are dietary epidemiology observations frequently not confirmed by the randomized clinical trial? We call the identified problems "fishing with only one bait" and the "four-legged stool problem." The considerations identified in this analysis offer a number of possible solutions to puzzling findings: (a) Fruits and vegetables consistently show a protective effect against cancer in observational studies because they represent the entire "biological action package." (b) Dietary compounds show a protective effect in observational studies, but not in clinical trials, because this is an inevitable consequence of one compound being falsely identified as the active agent in a system in which multiple agents or multiple interacting regulatory molecules underlie the biological effect. The consequences are serious for trying to use epidemiology to identify effective nutritional compounds. The major conclusion has to be as follows: Supplementation with single dietary compounds is rarely going to be as effective as epidemiologic studies suggest; it is the biological action package that determines efficacy. Options for how we should move forward will be discussed. Dietary observational epidemiology is complex and involves many biases and confounders. We need to be more critical in the design of large randomized trials based on observational epidemiology or analysis. Rules of evidence are frequently ignored or misunderstood although the limitations of observational epidemiology are analogous to the problems associated with discovery-based research and biomarker identification. We need to be much more self-critical in the important and critical assessment of dietary compounds and their role in cancer prevention given the very high appeal for this approach both within the lay and scientific communities.

This article has been cited by other articles:

				P. M Rothwell and M. Bhatia Reporting of observational studies BMJ, October 20, 2007; 335(7624): 783 - 784. [Full Text] [PDF]

				E. Flossmann and P. M Rothwell Commentary: Aspirin and colorectal cancer an epidemiological success story Int. J. Epidemiol., October 1, 2007; 36(5): 962 - 965. [Full Text] [PDF]

				H. Shapiro, P. Singer, Z. Halpern, and R. Bruck Polyphenols in the treatment of inflammatory bowel disease and acute pancreatitis Gut, March 1, 2007; 56(3): 426 - 436. [Full Text] [PDF]

				J. P. Fruehauf and F. L. Meyskens Jr. Reactive Oxygen Species: A Breath of Life or Death? Clin. Cancer Res., February 1, 2007; 13(3): 789 - 794. [Abstract] [Full Text] [PDF]

				M. Plummer, J. Vivas, G. Lopez, J. C. Bravo, S. Peraza, E. Carillo, E. Cano, D. Castro, O. Andrade, V. Sanchez, et al. Chemoprevention of Precancerous Gastric Lesions With Antioxidant Vitamin Supplementation: A Randomized Trial in a High-Risk Population J Natl Cancer Inst, January 17, 2007; 99(2): 137 - 146. [Abstract] [Full Text] [PDF]

				L. Fontana, S. Klein, and J. O Holloszy Long-term low-protein, low-calorie diet and endurance exercise modulate metabolic factors associated with cancer risk Am. J. Clinical Nutrition, December 1, 2006; 84(6): 1456 - 1462. [Abstract] [Full Text] [PDF]

				M. E Wright, K. A Lawson, S. J Weinstein, P. Pietinen, P. R Taylor, J. Virtamo, and D. Albanes Higher baseline serum concentrations of vitamin E are associated with lower total and cause-specific mortality in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am. J. Clinical Nutrition, November 1, 2006; 84(5): 1200 - 1207. [Abstract] [Full Text] [PDF]

				F. L. Meyskens Jr. American Society of Preventive Oncology Distinguished Career Achievement Lecture 2006--Enjoy the Journey: The Long and Winding Road of Chemoprevention Agent Development. Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2038 - 2041. [Full Text] [PDF]

				C. Doyle, L. H. Kushi, T. Byers, K. S. Courneya, W. Demark-Wahnefried, B. Grant, A. McTiernan, C. L. Rock, C. Thompson, T. Gansler, et al. Nutrition and Physical Activity During and After Cancer Treatment: An American Cancer Society Guide for Informed Choices CA Cancer J Clin, November 1, 2006; 56(6): 323 - 353. [Abstract] [Full Text] [PDF]

				L. H. Kushi, T. Byers, C. Doyle, E. V. Bandera, M. McCullough, T. Gansler, K. S. Andrews, M. J. Thun, and The American Cancer Society 2006 Nutrition and Phy American Cancer Society Guidelines on Nutrition and Physical Activity for Cancer Prevention: Reducing the Risk of Cancer With Healthy Food Choices and Physical Activity CA Cancer J Clin, September 1, 2006; 56(5): 254 - 281. [Abstract] [Full Text] [PDF]

				C. M. Ulrich and J. D. Potter Folate supplementation: too much of a good thing? Cancer Epidemiol. Biomarkers Prev., February 1, 2006; 15(2): 189 - 193. [Full Text] [PDF]

				E. T.H. Fontham, P. Correa, R. Mera, L. E. Bravo, J. C. Bravo, M. B. Piazuelo, and M. C. Camargo Duration of Exposure, a Neglected Factor in Chemoprevention Trials Cancer Epidemiol. Biomarkers Prev., November 1, 2005; 14(11): 2465 - 2466. [Full Text] [PDF]